Impaired neurosteroid synthesis in multiple sclerosis

Brain

Volumn 134, Issue 9, 2011, Pages 2703-2721

  Noorbakhsh, Farshid ^a,b   Ellestad, Kristofor K ^a   Maingat, Ferdinand ^a   Warren, Kenneth G ^a   Han, May H ^c   Steinman, Lawrence ^c   Baker, Glen B ^a   Power, Christopher ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c STANFORD UNIVERSITY   (United States)

Author keywords

experimental autoimmune encephalomyelitis; microRNA; multiple sclerosis; neurosteroid

Indexed keywords

20ALPHA3ALPHA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA HYDROXYSTEROID DEHYDROGENASE 3; CD3EPSILON PROTEIN; CELL PROTEIN; HYDROXYSTEROID DEHYDROGENASE; IBA1 PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MICRORNA; MYELIN; NEUROSTEROID; PRASTERONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CELL PROTECTION; CELL STRAIN HEK293; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; ENCEPHALITIS; ENZYME ACTIVITY; FEMALE; GAS CHROMATOGRAPHY; GENE SILENCING; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; MALE; MASS SPECTROMETRY; MONOCYTE; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROIDOGENESIS; TISSUE MICROARRAY; UPREGULATION; WHITE MATTER;

EID: 80052925627     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr200     Document Type: Article

References (70)

1. Ahboucha S, Butterworth RF, Pomier-Layrargues G, Vincent C, Hassoun Z, Baker GB. Neuroactive steroids and fatigue severity in patients with primary biliary cirrhosis and hepatitis C. Neurogastroenterol Motil 2008; 20: 671-9. (Pubitemid 351678619)
2. Alam S, Laughton DL, Walding A, Wolstenholme AJ. Human peripheral blood mononuclear cells express GABAA receptor subunits. Mol Immunol 2006; 43: 1432-42. (Pubitemid 43356383)
3. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001; 28; 107: 823-6. (Pubitemid 34084973)
4. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-5. (Pubitemid 39265675)
5. Asli NS, Pitulescu ME, Kessel M. MicroRNAs in organogenesis and disease. Curr Mol Med 2008; 8: 698-710.
6. Barbaccia ML. Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs. Crit Rev Neurobiol 2004; 16: 67-74. (Pubitemid 39586904)
7. Bhat R, Axtell R, Mitra A, Miranda M, Lock C, Tsien RW, et al. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci USA 2010; 107: 2580-5.
8. Bhat R, Steinman L. Innate and adaptive autoimmunity directed to the central nervous system. Neuron 2009; 64: 123-32.
9. Brinton RD, Wang JM. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. Curr Alzheimer Res 2006; 3: 185-90. (Pubitemid 43988130)
10. Carrington JC, Ambros V. Role of microRNAs in plant and animal development. Science 2003; 301: 336-8. (Pubitemid 36877060)
11. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001; 294: 1731-5. (Pubitemid 33104847)
12. Charalampopoulos I, Remboutsika E, Margioris AN, Gravanis A. Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol Metab 2008; 19: 300-7.
13. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, et al. MicroRNA miR-326 regulates T(H)-17 differentiation and is associated with the pathogen-esis of multiple sclerosis. Nat Immunol 2009; 10: 1252-9.
14. Ellestad KK, Tsutsui S, Noorbakhsh F, Warren KG, Yong VW, Pittman QJ, et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol 2009; 183: 298-309.
15. Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000; 47: 391-5. (Pubitemid 30141854)
16. Filippi M, Rocca MA. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system. J Neurol 2005; 252 (Suppl 5): v16-24. (Pubitemid 41532351)
17. Ge S, Pradhan DA, Ming GL, Song H. GABA sets the tempo for activity-dependent adult neurogenesis. Trends Neurosci 2007; 30: 1-8. (Pubitemid 46001680)
18. Ghoumari AM, Baulieu EE, Schumacher M. Progesterone increases oligo-dendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 2005; 135: 47-58. (Pubitemid 41219737)
19. Ghoumari AM, Ibanez C, El-Etr M, Leclerc P, Eychenne B, O'Malley BW, et al. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem 2003; 86: 848-59. (Pubitemid 36988797)
20. Giatti S, D'Intino G, Maschi O, Pesaresi M, Garcia-Segura LM, Calza L, et al. Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochem Int 2010; 56: 118-27.
21. Goascogne C, Gouezou M, Robel P, Defaye G, Chambaz E, Waterman MR, et al. The cholesterol side-chain cleavage complex in human brain white matter. J Neuroendocrinol 1989; 1: 153-6.
22. Griffin LD, Gong W, Verot L, Mellon SH. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnano-lone. Nat Med 2004; 10: 704-11. (Pubitemid 38937635)
23. Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010; 466: 835-40.
24. Han MH, Hwang SI, Roy DB, Lundgren DH, Price JV, Ousman SS, et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2008; 451: 1076-81. (Pubitemid 351317445)
25. Hebert SS, De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci 2009; 32: 199-206.
26. Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 2008; 105: 6415-20. (Pubitemid 351758360)
27. Hosie AM, Wilkins ME, Smart TG. Neurosteroid binding sites on GABA(A) receptors. Pharmacol Ther 2007; 116: 7-19. (Pubitemid 47398919)
28. Hu ZY, Bourreau E, Jung-Testas I, Robel P, Baulieu EE. Neurosteroids: oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc Natl Acad Sci USA 1987; 84: 8215-9. (Pubitemid 18033446)
29. Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis 2008; 29: 438-45.
30. Johnston GA. GABAA receptor pharmacology. Pharmacol Ther 1996; 69: 173-98.
31. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 2009; 132 (Pt 12): 3342-52.
32. Kanter JL, Narayana S, Ho PP, Catz I, Warren KG, Sobel RA, et al. Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 2006; 12: 138-43. (Pubitemid 43050089)
33. Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009; 4: e7440.
34. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007; 317: 1220-4.
35. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-50. (Pubitemid 44430905)
36. Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA. Neurosteroid modulation of GABAA receptors. Prog Neurobiol 2003; 71: 67-80.
37. Laxer K, Blum D, Abou-Khalil BW, Morrell MJ, Lee DA, Data JL, et al. Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design. Ganaxolone Presurgical Study Group. Epilepsia 2000; 41: 1187-94.
38. Le Melledo JM, Baker GB. Neuroactive steroids and anxiety disorders. J Psychiatry Neurosci 2002; 27: 161-5. (Pubitemid 34693926)
39. Lindberg RL, De Groot CJ, Certa U, Ravid R, Hoffmann F, Kappos L, et al. Multiple sclerosis as a generalized CNS disease-comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS. J Neuroimmunol 2004; 152: 154-67. (Pubitemid 38829713)
40. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002; 8: 500-8. (Pubitemid 34546753)
41. MacKenzie EM, Odontiadis J, Le Melledo JM, Prior TI, Baker GB. The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders. Cell Mol Neurobiol 2007; 27: 541-74. (Pubitemid 47038103)
42. Martini L, Magnaghi V, Melcangi RC. Actions of progesterone and its 5alpha-reduced metabolites on the major proteins of the myelin of the peripheral nervous system. Steroids 2003; 68: 825-9. (Pubitemid 37532406)
43. Mellon SH. Neurosteroid regulation of central nervous system development. Pharmacol Ther 2007; 116: 107-24. (Pubitemid 47391034)
44. Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab 2002; 13: 35-43. (Pubitemid 36734014)
45. Miller DH, Thompson AJ, Filippi M. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 2003; 250: 1407-19. (Pubitemid 38121836)
46. Noorbakhsh F, Overall CM, Power C. Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci 2009; 32: 88-100.
47. Noorbakhsh F, Ramachandran R, Barsby N, Ellestad KK, Leblanc A, Dickie P, et al. MicroRNA profiling reveals new aspects of HIV neuro-degeneration: caspase-6 regulates astrocyte survival. FASEB J 2010; 24: 1799-812.
48. Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, et al. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 2006; 203: 425-35. (Pubitemid 43290851)
49. Noorbakhsh F, Vergnolle N, McArthur JC, Silva C, Vodjgani M, Andrade-Gordon P, et al. Proteinase-activated receptor-2 induction by neuroin-flammation prevents neuronal death during HIV infection. J Immunol 2005; 174: 7320-9. (Pubitemid 40705702)
50. Oh LY, Larsen PH, Krekoski CA, Edwards DR, Donovan F, Werb Z, et al. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 1999; 19: 8464-75. (Pubitemid 30226765)
51. Otaegui D, Baranzini SE, Armananzas R, Calvo B, Munoz-Culla M, Khankhanian P, et al. Differential micro-RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009; 4: e6309.
52. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, et al. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 2000; 351 (Pt 1): 67-77.
53. Pieribone VA, Tsai J, Soufflet C, Rey E, Shaw K, Giller E, et al. Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy. Epilepsia 2007; 48: 1870-4. (Pubitemid 47537451)
54. Power C, Henry S, Del Bigio MR, Larsen PH, Corbett D, Imai Y, et al. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol 2003; 53: 731-42. (Pubitemid 36622510)
55. Roshan R, Ghosh T, Scaria V, Pillai B. MicroRNAs: novel therapeutic targets in neurodegenerative diseases. Drug Discov Today 2009; 14: 1123-9.
56. Rupprecht R, Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends Neurosci 1999; 22: 410-6. (Pubitemid 29453646)
57. Sakamoto H, Ukena K, Tsutsui K. Dendritic spine formation in response to progesterone synthesized de novo in the developing Purkinje cell in rats. Neurosci Lett 2002; 322: 111-5. (Pubitemid 34212033)
58. Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJ, Garcia-Segura LM, et al. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 2003; 71: 3-29. (Pubitemid 37377932)
59. Sedlacek M, Korinek M, Petrovic M, Cais O, Adamusova E, Chodounska H, et al. Neurosteroid modulation of ionotropic glutamate receptors and excitatory synaptic transmission. Physiol Res 2008; 57 (Suppl 3): S49-57.
60. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23: 683-747. (Pubitemid 40563183)
61. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008; 31: 247-69.
62. Tsutsui S, Schnermann J, Noorbakhsh F, Henry S, Yong VW, Winston BW, et al. A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. J Neurosci 2004; 24: 1521-9. (Pubitemid 38223004)
63. van der Valk P, Amor S. Preactive lesions in multiple sclerosis. Curr Opin Neurol 2009; 22: 207-13.
64. Vergnes L, Phan J, Stolz A, Reue K. A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13. J Lipid Res 2003; 44: 503-11. (Pubitemid 37287563)
65. Wang JM, Johnston PB, Ball BG, Brinton RD. The neurosteroid allopreg-nanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J Neurosci 2005; 25: 4706-18. (Pubitemid 40664119)
66. Wang JM, Liu L, Irwin RW, Chen S, Brinton RD. Regenerative potential of allopregnanolone. Brain Res Rev 2008a; 57: 398-409. (Pubitemid 351381778)
67. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008b; 28: 1213-23. (Pubitemid 351186356)
68. Weinberg MS, Wood MJ. Short non-coding RNA biology and neurode-generative disorders: novel disease targets and therapeutics. Hum Mol Genet 2009; 18: R27-39.
69. Zhang Z, Yang R, Zhou R, Li L, Sokabe M, Chen L. Progesterone promotes the survival of newborn neurons in the dentate gyrus of adult male mice. Hippocampus 2010; 20: 402-12.
70. Zhu Y, Vergote D, Pardo C, Noorbakhsh F, McArthur JC, Hollenberg MD, et al. CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy. FASEB J 2009; 23: 2928-41.